Biotechnology Newsfeed
Choose content
Create your own custom newsfeed
|
Set preferences
Set up your newsfeed details, look and feel and desired output
|
Create account
Enter your registration information
|
-
Centre for DNA Fingerprinting and Diagnostics (CDFD), Inner Ring Road, Uppal, Hyderabad - 500 039; a research Institution under the Biotechnology Research and ...
05 Oct 2024 13:19 GMT
Mathrubhumi
… ; a research Institution under the Biotechnology Research and Innovation Council (BRIC … ), Department of Biotechnology, Ministry of Science and Technology … program of Regional Centre for Biotechnology. CDFD’s Research Scholars Program …
-
Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
03 Oct 2024 20:08 GMT
Business Wire
Vir Biotechnology, Inc. (NASDAQ:VIR) today announced … 30 days. About Vir Biotechnology, Inc. Vir Biotechnology, Inc. is a clinical …
-
TNAU ties up with start-ups, innovators for high-end research at Centre of Excellence in Biotechnology
03 Oct 2024 14:37 GMT
The Hindu
… its Centre of Excellence in Biotechnology (CoEB) under public-private partnership … , Director, Centre of Excellence in Biotechnology and CPMB and B, signed …
-
NIIT University (NU) partners with Victoria University of Wellington (VUW) for Bachelor’s Programme in Biotechnology
03 Oct 2024 12:11 GMT
India Education Diary
… evolving demands of the global biotechnology sector. Victoria University of Wellington … world-class opportunities to our biotechnology students.” Martin Quietzsch, Senior … significant contributions to the global biotechnology landscape. We look forward to …
-
Biotechnology company launches cancer vaccine trial for dogs
02 Oct 2024 21:55 GMT
dvm360
… (HSA) is underway. Calviri, a biotechnology company that creates therapeutic and …
-
M42’s Environmental Sciences team wins Biotechnology - Environmental Services Award at Middle East Technology Excellence Awards 2024
02 Oct 2024 08:09 GMT
Eye of Riyadh
… team has won the prestigious Biotechnology - Environmental Services Award at … project demonstrates the potential of biotechnology in environmental services and reinforces …
-
Luxa Biotechnology Appoints Dionne CEO
01 Oct 2024 17:42 GMT
New Jersey Business Magazine
… Lee-based Luxa Biotechnology LLC, a clinical -stage biotechnology company developing a … therapy field and a seasoned biotechnology executive, Dr. Dionne brings three … experience leading US and international biotechnology companies as well as multiple …
-
Light-based microcapillary monitoring sparks innovation in manufacturing and biotechnology
01 Oct 2024 15:00 GMT
Phys.org
… such as 3D printing, displays, biotechnology, electroplating, and microelectronics. The simplicity … sparks innovation in manufacturing and biotechnology (2024, October 1) retrieved … 47;2024-10-based-microcapillary-biotechnology.html This document is subject …
-
Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
01 Oct 2024 12:04 GMT
Business Wire
… Luxa), a clinical -stage biotechnology company developing a novel … therapy field and a seasoned biotechnology executive, Dr. Dionne … U.S. and international biotechnology companies as well as … to fill. About Luxa Biotechnology Luxa Biotechnology (Luxa) is a …
-
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
04 Oct 2024 11:30 GMT
GlobeNewswire, Inc.
… global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories …
-
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
04 Oct 2024 11:20 GMT
GlobeNewswire, Inc.
… global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories …
-
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
03 Oct 2024 20:45 GMT
GlobeNewswire, Inc.
… . Onconetix is a commercial stage biotechnology company focused on the research … , regulatory approval and commercialization of biotechnology products. Onconetix does not undertake …
-
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
03 Oct 2024 20:05 GMT
GlobeNewswire, Inc.
… global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories …
-
SpiroChem and Arctoris Announce Strategic Partnership and Launch Joint Offering to Accelerate Drug Discovery
03 Oct 2024 14:32 GMT
EIN Presswire
… drug discovery processes for biotechnology and pharmaceutical companies worldwide … drug discovery solutions for biotechnology and pharmaceutical companies worldwide. … serving global pharmaceutical and biotechnology companies with proprietary libraries …
-
Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
03 Oct 2024 13:05 GMT
GlobeNewswire, Inc.
… . Onconetix is a commercial stage biotechnology company focused on the research … , regulatory approval and commercialization of biotechnology products. Onconetix does not undertake …
-
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024
03 Oct 2024 12:00 GMT
GlobeNewswire, Inc.
… SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to … , Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to …
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Oct 2024 11:00 GMT
GlobeNewswire, Inc.
… BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment …
-
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
02 Oct 2024 20:05 GMT
GlobeNewswire, Inc.
… of leadership experience for emerging biotechnology companies and will be instrumental … Codexis significant experience as a biotechnology and pharmaceutical executive, including an …
-
PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation
02 Oct 2024 12:00 GMT
GlobeNewswire, Inc.
… , 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech … :1144-53. About PDS Biotechnology PDS Biotechnology is a late-stage immunotherapy … ® are registered trademarks of PDS Biotechnology Corporation. Investor Contact: Mike Moyer …
-
EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields
02 Oct 2024 13:00 GMT
GlobeNewswire, Inc.
… twenty research partnerships worldwide, with biotechnology companies, pharmaceutical laboratories dedicated to …
-
BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome
02 Oct 2024 11:00 GMT
GlobeNewswire, Inc.
… BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment …
-
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
02 Oct 2024 10:30 GMT
GlobeNewswire, Inc.
… .com) is a clinical-stage biotechnology company engaged in the development …
-
Replimune to Present at Two Upcoming Investor Conferences
01 Oct 2024 12:00 GMT
GlobeNewswire, Inc.
… . (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of …
-
Foghorn Therapeutics to Participate in the BMO Oncology Summit
01 Oct 2024 11:00 GMT
GlobeNewswire, Inc.
… . (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class …